Your browser doesn't support javascript.
loading
Endogenous cortisol excess confers a unique lipid signature and metabolic network.
Vega-Beyhart, Arturo; Iruarrizaga, Marta; Pané, Adriana; García-Eguren, Guillermo; Giró, Oriol; Boswell, Laura; Aranda, Gloria; Flores, Vanesa; Casals, Gregori; Alonso, Cristina; Mora, Mireia; Halperin, Irene; Carmona, Francesc; Enseñat, Joaquim; Vidal, Oscar; Hu, Ting; Rojo, Gemma; Gomis, Ramon; Hanzu, Felicia A.
Afiliação
  • Vega-Beyhart A; Group of Endocrine Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Carrer Rosselló, 149, 08036, Barcelona, Spain.
  • Iruarrizaga M; Endocrinology and Nutrition Department, Hospital Clínic, Barcelona, Spain.
  • Pané A; OWL Metabolomics, Derio, Spain.
  • García-Eguren G; Endocrinology and Nutrition Department, Hospital Clínic, Barcelona, Spain.
  • Giró O; Group of Endocrine Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Carrer Rosselló, 149, 08036, Barcelona, Spain.
  • Boswell L; Group of Endocrine Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Carrer Rosselló, 149, 08036, Barcelona, Spain.
  • Aranda G; Group of Endocrine Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Carrer Rosselló, 149, 08036, Barcelona, Spain.
  • Flores V; Endocrinology and Nutrition Department, Hospital Clínic, Barcelona, Spain.
  • Casals G; Group of Endocrine Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Carrer Rosselló, 149, 08036, Barcelona, Spain.
  • Alonso C; Group of Endocrine Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Carrer Rosselló, 149, 08036, Barcelona, Spain.
  • Mora M; Endocrinology and Nutrition Department, Hospital Clínic, Barcelona, Spain.
  • Halperin I; Biomedical diagnostics Centre, Hospital Clínic, Barcelona, Spain.
  • Carmona F; OWL Metabolomics, Derio, Spain.
  • Enseñat J; Group of Endocrine Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Carrer Rosselló, 149, 08036, Barcelona, Spain.
  • Vidal O; Endocrinology and Nutrition Department, Hospital Clínic, Barcelona, Spain.
  • Hu T; Group of Endocrine Disorders, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Carrer Rosselló, 149, 08036, Barcelona, Spain.
  • Rojo G; Endocrinology and Nutrition Department, Hospital Clínic, Barcelona, Spain.
  • Gomis R; Surgery Department, Hospital Clínic, Barcelona, Spain.
  • Hanzu FA; Surgery Department, Hospital Clínic, Barcelona, Spain.
J Mol Med (Berl) ; 99(8): 1085-1099, 2021 08.
Article em En | MEDLINE | ID: mdl-33881561
Chronic cortisol excess induces several alterations on protein, lipid and carbohydrate metabolism resembling those found in the metabolic syndrome. However, patients exposed to prolonged high levels of cortisol in Cushing syndrome (CS) present exceeding cardiometabolic alterations not reflected by conventional biomarkers. Using 3 ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS) platforms, we aimed to characterise the serum metabolome of 25 patients with active endogenous CS and 25 control subjects matched by propensity score (sex, BMI, diabetes mellitus type 2 (T2D), high blood pressure (HBP) and dyslipidaemia) to search for potential disease-specific biomarkers and pathways associated to the clinical comorbidities. A total of 93 metabolites were significantly altered in patients with CS. Increased levels of sulfur amino acids (AA), triacylglycerols, glycerophospholipids, ceramides and cholesteryl esters were observed. Contrarily, concentrations of essential and non-essential AA, polyunsaturated fatty acids, conjugated bile acids and second messenger glycerolipids were decreased. Twenty-four-hour urinary free cortisol (24h-UFC) independently determined the concentration of 21 lipids and 4 AA. A metabolic signature composed by 10 AA and 10 lipid metabolites presented an AUC-ROC of 95% for the classification of CS patients. Through differential network analysis, 152 aberrant associations between metabolites involved in the Lands cycle and Kennedy pathway were identified. Our data indicates that chronic hypercortisolemia confers a unique lipidomic signature and several alterations in numerous AA even when compared to patients with similar metabolic comorbidities providing novel insights of the increased cardiometabolic burden of CS. KEY MESSAGES: • Cortisol excess induces metabolic alterations beyond conventional biomarkers. • The hypercortisolism extent determines the concentration of 21 lipids and 5 aa. • Cortisol excess confers a unique metabolic signature of 20 metabolites. • Kennedy and Lands cycle are profoundly disturbed by cortisol excess.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidrocortisona / Metabolismo dos Lipídeos / Redes e Vias Metabólicas / Lipidômica Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hidrocortisona / Metabolismo dos Lipídeos / Redes e Vias Metabólicas / Lipidômica Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article